Immunology and growth characteristics of ocular basal cell carcinoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 239, Issue 1, 2001, Pages 35-40

  Rohrbach, J M ^a   Stiemer, Rainer ^b   Mayer, Anita ^b   Riedinger, Claudia ^b   Duijvestijn, Adrian ^c   Zierhut, Manfred ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; EPITOPE; INTERCELLULAR ADHESION MOLECULE 3; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER IMMUNOLOGY; CELL AGGREGATION; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXCISION; EYE CANCER; EYELID; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, BASAL CELL; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; EYELID NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035146860     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170000221     Document Type: Article

References (24)

1. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma
2. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma
3. Intralesional interferon therapy for basal cell carcinoma
4. Immune-associated cells in basal cell carcinomas of skin
5. Cytotoxic T cells in basal cell carcinomas of skin
6. P53 mutations and chromosome instability in basal cell carcinomas developed at an early or late stage
7. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas
8. Characterization of the mononuclear infiltrate in basal cell carcinoma: A predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells
9. Spontaneous regression of human melanoma/nonmelanoma skin cancer: Association with infiltrating CD4+ T cells
10. Prognostic value of Ki67 antigen expression in basal cell carcinomas
11. Regression in basal cell carcinoma: An immunohistochemical analysis
12. Basal cell carcinoma treated with interferon
13. IL-10 production in cutaneous basal and squamous cell carcinomas
14. Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma: Decreased expression of IFN-γR and shedding of ICAM-1 as a surveillance
15. Basal cell carcinoma of the eyelid and periocular skin
16. Characterization of p53 gene mutations in basal-cell carcinomas: Comparison between sun-exposed and less-exposed skin areas
17. Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1)
18. P53 gene mutations in human epithelial skin cancers
19. Immunohistochemical analysis of p53 protein expression in benign and malignant skin tumors using a panel of anti-p53 antibodies
20. Transforming growth factor-β distribution in basal cell carcinomas: Relationship to proliferation index
21. Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery
22. Proliferating cell nuclear antigen (PCNA); prognostic value in the clinical recurrence of primary basal cell carcinoma
23. Molecular regulation of apoptosis: Genetic controls on cell death
24. Expression of cutaneous lymphocyte-associated antigen defined by monoclonal antibody HECA-452 on human Langerhans cells